151 related articles for article (PubMed ID: 36994643)
1. Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables.
Akhan O; Erdemir AG; Karahan S; Ünal E; Çiftçi TT; Akıncı D; Yalçın Ş
Diagn Interv Radiol; 2024 May; 30(3):183-192. PubMed ID: 36994643
[TBL] [Abstract][Full Text] [Related]
2. Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
van der Reijd DJ; Guerendel C; Staal FCR; Busard MP; De Oliveira Taveira M; Klompenhouwer EG; Kuhlmann KFD; Moelker A; Verhoef C; Starmans MPA; Lambregts DMJ; Beets-Tan RGH; Benson S; Maas M
Eur Radiol; 2024 Jun; 34(6):3635-3643. PubMed ID: 37987835
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy.
Liu M; Huang GL; Xu M; Pan FS; Lu MD; Zheng KG; Kuang M; Xie XY
Int J Hyperthermia; 2017 Jun; 33(4):446-453. PubMed ID: 28044471
[TBL] [Abstract][Full Text] [Related]
4. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
[TBL] [Abstract][Full Text] [Related]
5. Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases.
Serenari M; Ratti F; Stocco A; De Cobelli F; Serra C; Santangelo D; Fallani G; Della Corte A; Marino R; Ravaioli M; Aldrighetti L; Cescon M
Surg Endosc; 2024 May; 38(5):2611-2621. PubMed ID: 38499784
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intrahepatic progression patterns of hepatocellular carcinoma and colorectal liver metastases following CT-guided high dose-rate brachytherapy.
Xu H; Schmidt R; Hamm CA; Schobert IT; He Y; Böning G; Jonczyk M; Hamm B; Gebauer B; Savic LJ
Ther Adv Med Oncol; 2021; 13():17588359211042304. PubMed ID: 34539817
[TBL] [Abstract][Full Text] [Related]
7. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes.
Mukund A; Vats P; Jindal A; Patidar Y; Sarin SK
J Clin Exp Hepatol; 2020; 10(6):563-573. PubMed ID: 33311893
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
Front Oncol; 2021; 11():758552. PubMed ID: 34745996
[TBL] [Abstract][Full Text] [Related]
9. Intraprocedural Versus Initial Follow-up Minimal Ablative Margin Assessment After Colorectal Liver Metastasis Thermal Ablation: Which One Better Predicts Local Outcomes?
Lin YM; Paolucci I; Albuquerque Marques Silva J; O'Connor CS; Fellman BM; Jones AK; Kuban JD; Huang SY; Metwalli ZA; Brock KK; Odisio BC
Invest Radiol; 2024 Apr; 59(4):314-319. PubMed ID: 37812469
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance.
Peng S; Huang P; Yu H; Wen Y; Luo Y; Wang X; Zhou J; Qin S; Li T; Chen Y; Liu G; Huang M
Medicine (Baltimore); 2018 Mar; 97(10):e0044. PubMed ID: 29517661
[TBL] [Abstract][Full Text] [Related]
13. MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
Li Z; Wang C; Li J; Liu Z; Jiao D; Han X
BMC Cancer; 2021 May; 21(1):562. PubMed ID: 34001036
[TBL] [Abstract][Full Text] [Related]
14. Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients.
Hermida M; Cassinotto C; Piron L; Aho-Glélé S; Guillot C; Schembri V; Allimant C; Jaber S; Pageaux GP; Assenat E; Guiu B
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32013112
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases.
Liu C; He J; Li T; Hong D; Su H; Shao H
Abdom Radiol (NY); 2021 May; 46(5):2161-2172. PubMed ID: 33108496
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Zhuang BW; Li W; Qiao B; Zhang N; Lin MX; Wang W; Kuang M; Lu MD; Xie XY; Xie XH
Int J Hyperthermia; 2022; 39(1):1143-1151. PubMed ID: 36039777
[TBL] [Abstract][Full Text] [Related]
17. Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts.
Puijk RS; Ziedses des Plantes V; Nieuwenhuizen S; Ruarus AH; Vroomen LGPH; de Jong MC; Geboers B; Hoedemaker-Boon CJ; Thöne-Passchier DH; Gerçek CC; de Vries JJJ; van den Tol PMP; Scheffer HJ; Meijerink MR
Cardiovasc Intervent Radiol; 2019 Nov; 42(11):1597-1608. PubMed ID: 31243542
[TBL] [Abstract][Full Text] [Related]
18. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
Wang CZ; Yan GX; Xin H; Liu ZY
World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
[TBL] [Abstract][Full Text] [Related]
19. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.
Chinnaratha MA; Sathananthan D; Pateria P; Tse E; MacQuillan G; Mosel L; Pathi R; Madigan D; Wigg AJ
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):349-54. PubMed ID: 25563141
[TBL] [Abstract][Full Text] [Related]
20. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center.
Qin S; Liu GJ; Huang M; Huang J; Luo Y; Wen Y; Wang Y; Chen L
Int J Hyperthermia; 2019; 36(1):36-43. PubMed ID: 30489175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
